Patent · US Active

Anti-LRP6 antibodies

US9556267B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2014
Grant dateJan 31, 2017
Priority date
Expiry dateAug 22, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-LRP6 antibodies and methods of using the same. A particular aspect of the invention provides for bispecific anti-LRP6 antibodies that inhibit signaling by multiple Wnt isoforms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.